Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Abstract
Genomic classifiers (GC) have been shown to improve risk stratification post prostatectomy. However, their clinical benefit has not been prospectively demonstrated. We sought to determine the impact of GC testing on postoperative management in men with prostate cancer post prostatectomy.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 12, 2019
- Source ID
- 10.1038/s41391-019-0185-7
Entities
People
- Adam P. Dicker
- Anne Calvaresi
- Bashar Dabbas
- Costas D. Lallas
- Daniel E. Spratt
- Daniel W Lin
- Edouard J Trabulsi
- Elai Davicioni
- J. Ryan Mark
- James L. Godwin
- Jingbin Zhang
- John L. Gore
- Joseph Marascio
- Karen E. Knudsen
- Leonard G. Gomella
- Mark D. Hurwitz
- Mark Mann
- Matthew Bloom
- Peter Mccue
- Robert B. Den
- Tiffany Le
- W. Kevin Kelly
- Whitney H. Beeler
- Worlanyo Sosu Sedzorme
Organizations
- Center for Information Technology
- Prostate Cancer Foundation
- United States Department of Defense